The Alzheimer's Association International Conference® 2024 (AAIC®) was, as always, a reinvigorating time and a reflection of how far we've come in Alzheimer's disease and dementia research. The conference is just one way the Alzheimer's Association is working tirelessly to end Alzheimer's and all other dementia. I want to thank you for your part in making this year's conference a success, and for all you do to support our work in accelerating global research, as well as advancing early detection and providing care and support.
There were several key findings at this year's conference, encompassing everything from prevention and risk reduction to advancements in early detection and diagnosis and potential new treatment avenues. Throughout the week, scientists presented research that may make a difference in the lives of those impacted by Alzheimer's and all types of dementia. We learned about:
Blood tests that accurately and reliably detect Alzheimer's hallmark brain changes may soon signal a shift to simpler, less-expensive and less-invasive detection and diagnosis, and support volunteer recruitment for treatment trials.
GLP-1 agonists — one class of drugs prescribed to treat diabetes and weight loss — may also protect the brain. A study testing liraglutide in people living with mild Alzheimer's appeared to reduce shrinking by nearly 50% in parts of the brain that affect memory, learning, language and decision-making, when compared to a placebo.
The progress and breakthroughs we have made are all thanks to our supporters. Through the generosity of our supporters, we are able to provide the nearly 7 million Americans living with Alzheimer's and their over 11 million caregivers access to care and support services and accelerate critical research to improve methods for treatment, prevention and, ultimately, a cure.
Though we have made progress, our work is far from done. We won't rest until everyone living with dementia of any kind — at any stage — can get the treatment, care and support they need and deserve. I truly believe that the global collaboration demonstrated at AAIC will result in even more research discoveries. But it's only with your support that can we deliver on the promise of what we learn at AAIC.
Thank you for supporting our mission to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
Sincerely,
Maria C. Carrillo, Ph.D.
Chief Science Officer and Medical Affairs Lead
Your donation will strengthen our efforts to advance Alzheimer's care, support and research. From face-to-face support to online education programs and promising global research initiatives, your gift makes a difference in the lives of all those affected by Alzheimer's and other dementias in your community and across the world. Thank you for your continued support.
Please add [email protected] to your address book to ensure you receive all future emails.
Having trouble reading this email? View it in your browser
View your email preferences or unsubscribe.
